Stock AEGIR MAGNASENSE AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Magnasense AB

Equities

AEGIR

SE0014401121

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-07-10 pm EDT 		5-day change 1st Jan Change
0.4005 SEK -5.43% Intraday chart for Magnasense AB -6.86% -65.77%
Jul. 08 Sweden's AegirBio Changes Name to Magnasense MT
Jul. 08 AegirBio AB has Changed its Name to Magnasense AB CI

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 223.4 989.2 42.8 36.13
Enterprise Value (EV) 1 213.7 956.6 35.37 59.79
P/E ratio -3.03 x -9.29 x -0.11 x -0.49 x
Yield - - - -
Capitalization / Revenue - 74,477,032 x 25,088,991 x 392,673,261 x
EV / Revenue - 72,019,947 x 20,730,843 x 649,847,174 x
EV / EBITDA -3,453,176 x -13,009,764 x -456,482 x -1,478,021 x
EV / FCF -5,816,657 x -14,756,600 x -1,825,832 x -1,950,832 x
FCF Yield -0% -0% -0% -0%
Price to Book 6.64 x 2.67 x 1.07 x -24.9 x
Nbr of stocks (in thousands) 10,315 17,324 21,284 30,877
Reference price 2 21.66 57.10 2.011 1.170
Announcement Date 6/14/21 5/30/22 7/21/23 5/31/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023
Net sales - - 13.28 1.706 0.092
EBITDA - -61.89 -73.53 -77.48 -40.45
EBIT - -62.08 -81.52 -89.79 -56.16
Operating Margin - - -613.73% -5,263.31% -61,041.3%
Earnings before Tax (EBT) 1 -0.000248 -62.08 -92.66 -364.3 -61.19
Net income 1 -0.000248 -62.08 -92.33 -362.8 -59.7
Net margin - - -695.14% -21,267.88% -64,886.96%
EPS - -7.144 -6.143 -18.90 -2.383
Free Cash Flow - -36.74 -64.82 -19.37 -30.65
FCF margin - - -488.05% -1,135.42% -33,311.28%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 1/20/20 6/14/21 5/30/22 7/21/23 5/31/24
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt 1 - - - - 23.7
Net Cash position 1 0.05 9.7 32.6 7.44 -
Leverage (Debt/EBITDA) - - - - -0.5849 x
Free Cash Flow - -36.7 -64.8 -19.4 -30.6
ROE (net income / shareholders' equity) - -312% -45.1% -177% -311%
ROA (Net income/ Total Assets) - -172% -22.7% -23.8% -58.5%
Assets 1 - 36.12 406.5 1,523 102
Book Value Per Share 2 0.1400 3.260 21.40 1.870 -0.0500
Cash Flow per Share 2 0.0100 0.8700 1.960 0.6900 0.3900
Capex - 0.59 - 0.07 0.09
Capex / Sales - - - 3.81% 101.09%
Announcement Date 1/20/20 6/14/21 5/30/22 7/21/23 5/31/24
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
MAGNASENSE AB Stock Magnasense AB
-65.77% 1.45M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+1.15% 203B
DANAHER CORPORATION Stock Danaher Corporation
+4.69% 178B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+31.83% 157B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+33.39% 112B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+2.21% 64.58B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+22.99% 56.33B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-4.03% 46.75B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-8.60% 36.59B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+2.35% 35.09B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. AEGIR Stock
  4. Financials Magnasense AB